Anette Sommer, PhD

Head Bioconjugates Research at Lonza

Speaker

Anette Sommer is the Head of Bioconjugates Research at Lonza Advanced Synthesis – R&D. She was the Emerging Science & Innovation Lead (ESL) Oncology Europe at Pfizer. In this role, she was responsible for search and evaluation of novel preclinical stage opportunities and technologies for cancer therapies in Europe. Prior to joining Pfizer, Anette held several positions in drug discovery at Schering AG and Bayer AG, Berlin, Germany – covering all stages of the R&D value chain and with a focus on antibody-drug conjugates and radioconjugates. Anette is co-author of >50 scientific publications and >10 patent applications.